Alice Mushrooms

Alice Mushrooms, based in the US, specializes in producing functional mushroom-infused chocolates designed to enhance wellness, focus, and sleep quality, catering to health-conscious consumers. Alice Mushrooms was founded in 2022 in Venice, US, by Charlotte Cruze and Lindsay Goodstein. The company focuses on creating innovative chocolate products infused with functional mushrooms. Lindsay Goodstein serves as the CEO.

In September 2025, Alice Mushrooms raised USD 8 million in series A funding led by new investor NewBound Venture Capital, with participation from another new investor Unilever Ventures. Individual investors also participated in the round. Alice Mushrooms specializes in functional mushroom-infused chocolate products designed to enhance wellness, focus, and sleep quality. Their primary offerings include the "Nightcap," which promotes restful sleep; "Brainstorm," enhancing cognitive function and energy; and "Happy Ending," enhancing intimacy.

These products combine organic mushrooms, adaptogens, and nootropics in an enjoyable chocolate format, targeting health-conscious consumers across the United States. Products are available through their online platform and potentially through retailers and wellness-oriented marketplaces. Alice Mushrooms generates revenue primarily through direct-to-consumer sales via its e-commerce platform, emphasizing subscription models for repeat customers. The company offers various pricing structures, including single purchases and subscription options.

Key products like the limited edition "Alice x HBO Nightcap" and the "Brainstorm" chocolates attract both casual consumers and wellness enthusiasts, with transactions occurring online where customers can select their preferred delivery options. The company will use the September 2025 funding to develop new chocolate products and expand wholesale retail distribution into 1,300 stores across two major chains.